Recombinant Human RYR2 Protein，His

RYR2, or Ryanodine Receptor 2, is a crucial calcium release channel located in the sarcoplasmic reticulum of cardiac muscle cells, playing a vital role in the regulation of intracellular calcium levels and, consequently, cardiac contraction. Mutations in the RYR2 gene have been implicated in various cardiac conditions, including catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmias, highlighting its importance in cardiovascular health. Research on RYR2 recombinant proteins focuses on understanding the structural and functional characteristics of the receptor, particularly how specific mutations affect its calcium handling capabilities. This knowledge is essential for developing targeted therapies and interventions for patients with RYR2-associated cardiac disorders. By studying the recombinant RYR2 protein, scientists aim to unravel the molecular mechanisms underlying calcium signaling in heart cells, which may lead to novel pharmacological strategies to modulate RYR2 function and improve heart contractility in disease states. Overall, the study of RYR2 recombinant proteins represents a critical intersection of molecular biology and cardiology, with significant implications for advancing therapeutic approaches in treating cardiac dysregulation.